Truvian
PrivateLast Round
VC Round
Jul 17, 2024
Total Funding Raised
$176.3M
Company Overview
Truvian operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in July 2024.
Truvian is a healthcare technology company that develops an automated benchtop blood testing platform designed to provide lab-accurate diagnostic results in decentralized care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truvian Comparables
Compare Truvian with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vital | 92% | |
| Genalyte | 85% | |
| Osler Diagnostics | 85% |
For institutional investors. Book with your work email.
Truvian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 17, 2024 | ||||
| Debt | Sep 14, 2021 | ||||
| Series C | Feb 24, 2021 | ||||
| Series B | Nov 20, 2019 | ||||
| Series A | Sep 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Truvian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series C, VC Round, Series B |
| Wasson Enterprise | Series C |
| Pacific West Bank | Debt |
| Domain Associates | Series B, Series A |
| GreatPoint Ventures | Series C, Series B |
| Medical Excellence Capital | VC Round |
| General Catalyst | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Proprietary blood testing platform is currently under FDA review.
- Jan 13, 2025
Developing a comprehensive benchtop solution for blood testing.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 1, 2026
Truvian Sciences Inc. and Siemens Healthineers AG announced a strategic alliance in California to advance the TruVerus(TM) blood testing platform, with development, technical, manufacturing and commercial support and exploration of future diagnostic solutions.
For institutional investors. Book with your work email.
Truvian Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Truvian's valuation, stock price, and market status.
Is Truvian a public or private company?
Truvian is a private company.
What is the current stock price of Truvian?
Truvian is a private company, so its shares have no public market price. Caplight tracks Truvian's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Truvian worth (valuation)?
Valuation information for Truvian is not publicly available.
Can I buy Truvian stock?
Truvian shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Truvian's last funding round?
Truvian's most recent funding round was VC Round on July 17, 2024.
Who are the main investors in Truvian?
Key investors in Truvian include GreatPoint Ventures, GreatPoint Ventures, Wittington Ventures, TYH Ventures, George Weston Limited.
Will Truvian IPO soon?
No public IPO plans have been announced for Truvian.
How can I track Truvian secondary market activity?
Caplight tracks bids, offers, and trades in Truvian's shares on secondary markets.